⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4955062 | 1.00 | — | — | |
| SCHEMBL3679748 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL21056373 | 0.97 | SLC6A2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL17713614 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29951921 | 0.97 | — | — | |
| SCHEMBL82935 | 0.97 | — | — | |
| SCHEMBL158979 | 0.97 | SLC6A2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL21056379 | 0.97 | SLC6A2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL21056375 | 0.97 | SLC6A2 (0.33) | — | |
| SCHEMBL518835 | 0.97 | SLC6A2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49481-E1 | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | HOFFMANN-LA ROCHE INC. (US) | 2023-04-04 | — | — | US | claimed |
| CN-115873910-A | Application of transaminase in catalytic synthesis of lactam compounds and synthesis method of lactam compounds | 凯莱英生命科学技术(天津)有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114133337-A | Preparation method of 2-substituted lysine | 成都泰蓉生物科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| US-20210371422-A1 | MORPHINAN DERIVATIVE | NIPPON CHEMIPHAR CO., LTD. (JP) | 2021-12-02 | — | — | US | claimed |
| CN-105492439-B | Substituted dicyclic compound as bromine structural domain inhibitor | 齐尼思表观遗传学有限公司 | 2019-11-22 | — | — | CN | claimed |
| CN-110248926-A | LSD1 inhibitor and its preparation method and application | 南京明德新药研发有限公司 | 2019-09-17 | — | — | CN | claimed |
| CN-105431420-B | Diheteroaryl compounds and uses thereof | 豪夫迈·罗氏有限公司 | 2019-08-13 | — | — | CN | claimed |
| CN-106795156-B | 2- (morpholin-4-yl) -1, 7-naphthyridine | 拜耳制药股份公司 | 2019-07-30 | — | — | CN | claimed |
| CN-110049983-A | Medical compounds | 细胞中心有限公司 | 2019-07-23 | — | — | CN | claimed |
| CN-110036002-A | Medical compounds | 细胞中心有限公司 | 2019-07-19 | — | — | CN | claimed |
| CN-1138764-C | Isoxazole derivatives | ס����ҩ��ʽ���� | 2004-02-18 | — | — | CN | claimed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| CN-1378527-A | Biaryl ether derivatives useful as monoamine reuptake inhibitors | PFIZER PROD INC (US) | 2002-11-06 | — | — | CN | claimed |
| CN-1264388-A | Dolastatin 15 derivatives | ABSF AG (DE) | 2000-08-23 | — | — | CN | claimed |
| CN-1252794-A | Isoxazole derivatives | SUMITOMO PHARMA (JP) | 2000-05-10 | — | — | CN | claimed |
| EP-0991658-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-12 | — | — | EP | claimed |
| WO-1999003879-A1 | DOLASTATIN 15 DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-28 | — | — | WO | claimed |
| US-5856556-A | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | claimed |
| CN-1107468-A | Preparation of novel heterocyclic nonionic contrast medium for radiophotograph | SQUIBB & SONS INC (US) | 1995-08-30 | — | — | CN | claimed |
| CN-1049495-A | Butyro-derivative | CIBA GEIGY AG (CH) | 1991-02-27 | — | — | CN | claimed |